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Abstract: 
 
The Ebola virus is transmitted to people from wild animals and spreads in the human population through 
human-to-human transmission via direct contact with blood, secretions, organs or other bodily fluids of infected 
people, and with surfaces and materials contaminated with these fluids. In December 2019, a novel coronavirus 
disease (COVID-19) caused by severe acute respiratory syndrome-coronavirus-2 (SARS-COV-2) emerged in 
Wuhan, China, attracting the notice of regional authorities and rapidly drawing global attention. In less than 4 
months, COVID-19 spread through almost all countries and regions. The COVID-19 pandemic is wreaking havoc 
on the world economy, in addition to creating the current global public health crisis. According to the World 
Health Organization (WHO), 28,616 cases of Ebola were detected, and 11,310 people died during the outbreak in 
Guinea, Liberia and Sierra Leone. As of 17th December 2020, COVID-19 has killed 1,658,062 people, and positive 
cases have topped 74 million globally. Africa has suffered several outbreaks of Ebola Virus Disease (EVD); 
learning from the past is a good way to prepare for the future. We hope to highlight some of the lessons learnt 
from Africa’s response to previous epidemics that can help in the fight against the ravaging coronavirus 
pandemic.   
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Abstrait: 
Le virus Ebola est transmis aux humains par des animaux sauvages et se propage dans la population humaine 
par transmission interhumaine par contact direct avec du sang, des sécrétions, des organes ou d'autres fluides 
corporels de personnes infectées, et avec des surfaces et des matériaux contaminés par ces fluides. En 
décembre 2019, une nouvelle maladie à coronavirus (COVID-19) causée par le syndrome respiratoire aigu 
sévère-coronavirus-2 (SRAS-COV-2) est apparue à Wuhan, en Chine, attirant l'attention des autorités 
régionales et attirant rapidement l'attention mondiale. En moins de 4 mois, le COVID-19 s'est propagé dans 
presque tous les pays et régions. La pandémie de COVID-19 fait des ravages sur l'économie mondiale, en plus 
de créer la crise mondiale actuelle de santé publique. Selon l'Organisation mondiale de la santé (OMS), 28616 
cas d'Ebola ont été détectés et 11310 personnes sont décédées au cours de l'épidémie en Guinée, au Libéria et 
en Sierra Leone. Au 17 décembre 2020, le COVID-19 avait tué 1658062 personnes et les cas positifs 
dépassaient 74 million dans le monde. L'Afrique a souffert de plusieurs flambées de maladie à virus Ebola 




(MVE); apprendre du passé est un bon moyen de préparer l'avenir. Nous espérons mettre en évidence certaines 
des leçons tirées de la réponse de l’Afrique aux épidémies précédentes qui peuvent aider à lutter contre la 
pandémie ravageuse de coronavirus. 
Mots clés: Ebola, COVID-19, OMS, transmission, mondial 
Applying lessons of Ebola out- 
break response to the COVID-19 
pandemic response  
of community transmission; they must learn 
to report cases immediately and also partici- 
pate in contact tracing. This training will 
come by community engagement. 
 
 Vaccines have been crucial in the 
eradication of some deadly diseases such as 
smallpox and in reducing harms caused by 
these pathogens (5). The WHO states that 
2013-2016 West Africa Ebola outbreak which 
killed more than 11,300 people has exposed 
the importance of a vaccine. The necessity of 
a vaccine warranted the approval of an expe- 
rimental vaccine for use by the regulatory 
and ethics review boards in the Democratic 
Republic of Congo on May 29, 2017 (6). 
Therefore, following the resurgence of Ebola 
in DRC in April 2018, the ministry of health 
sprang into action, and on May 21, 2018 
began a radical but important ring vacci- 
nation using rVSV-ZEBOV to vaccinate pri- 
mary and secondary contacts of diagnosed 
cases. This proved very helpful as 3,796 ind- 
ividuals who were immediately vaccinated 
were not infected. Lesson learnt is that ‘what 
has worked before can work again’ as ring 
vaccination has been used before in the 
eradication of smallpox (7). The rVSV-ZEBOV 
vaccine produced by Merck went through cli- 
nical trials during the 2013-2015 West Africa 
Ebola epidemic and was found to be 100% 
efficacious, and was 97.5% effective in the 
2018 Kivu outbreak (8). 
 In the wake of COVID-19 pandemic, 
Hossain et al., (1) believes that fake news, 
rumours and doubts have been disseminated 
from all angles especially the social media, 
giving rise to mass panic and lack of confi- 
dence in the COVID-19 response by many 
communities. According to the Medicins Sans 
Frontieres (2), community engagement must 
form the cornerstone of any response as it 
was key in ending previous Ebola outbreaks 
in different parts of Africa. The World Health 
Organization (WHO) states that community 
engagement is very necessary in discovering 
new cases of Ebola virus disease (EVD) and 
in contact tracing of people sick with Ebola 
and community members need training in 
many aspects of the response so that they 
can contribute in ending the transmission of 
EVD. This was demonstrated when Ebola 
outbreak began in Sierra Leone in 2014, the 
ministry of health began a massive commu- 
nity-based intervention where community 
and religious leaders, volunteers and activists 
were trained on Ebola response from public 
sensitization to contact tracing, which was 
very helpful as 70.8% of 72 cases reported in 
three communities was done by trained local 
community members (3).   
 In responding to the 2014-2016 West 
Africa Ebola outbreak, the International Fede- 
ration of Red Cross (IFRC) and Red Crescent 
Societies (RCS) mobilized 600,000 commu- 
nity members as volunteers across 10 coun- 
tries in Africa. This was counted as a big 
success in the fight against Ebola epidemic as 
was corroborated my Mrs Khadidiatou Baro, 
an Ivorian, who said, “we did not know what 
quarantine was and why it is important for 
stopping Ebola. Many people would not allow 
any of their family members to be quaran- 
tined. But the Red Cross community engage- 
ment volunteers convinced us about the imp- 
ortance of quarantine and we now accept it in 
our communities” (4).    
 To achieve the goal of flattening the 
global SARS-COV-2 infection curve, commu- 
nity leaders, health workers, volunteers and 
various social groups within the communities 
must be made to champion the fight against 
COVID-19. Various communities especially in 
low -and - middle - income-countries (LMICs) 
without access to adequate information must 
realize the importance of social distancing 
and hygienic practices in breaking the chain 
 According to the Global Alliance for 
Vaccines and Immunization (GAVI) (9), ”dev- 
eloping a vaccine against COVID-19 is the 
most pressing challenge of our time”. COVID-
19 vaccine could be the game changer in the 
global struggle against COVID-19 pandemic, 
a view that was reaffirmed by Dr Seth 
Berkley, CEO of GAVI who believes that 
”COVAX is the only truly global solution to 
COVID-19 pandemic” (10). Calls have been 
made by funders, manufacturers and scien- 
tists to speed up the vaccine development, so 
far, 70 vaccines and numerous therapeutics 
are in clinical trials in different parts of the 
world (11). To show the importance of effec- 
tive vaccine, more than 150 countries have 
agreed to be part of the COVID-19 vaccine 
global access facility which will ensure the 
equitable distribution of the vaccines to par- 
ticipating countries through COVAX using the 
criteria of need, vulnerability and level of 
threat to determine further distribution of the 
vaccine when ready (10). Knowledge derived 
from Ebola and SARS-COV responses has 
contributed in some measure in designing 
innovative approaches for COVID-19 vaccine 




development which is expected to be the 
quickest vaccine development in history (12). 
Just like in DRC Ebola outbreak of 2018, a 
COVID-19 vaccine will assist in breaking the 
chain of transmission in the primary and 
secondary contacts of infected persons. It is 
expected that by the end of 2021, COVAX 
would have delivered more than 2 billion 
doses of safe and effective vaccines (10). 
security [22].     
 A joint international collaboration is 
necessary in the wake of COVID-19 pandemic 
(23,24). Thanh et al., (25) emphasized the 
importance of strong international coordi- 
nation between vaccine developers, regula- 
tors and other relevant stakeholders. Momt- 
azmanesh et al., (24) made 2 key observa- 
tions; first, the quick exchange of genomic 
sequence of COVID-19 by many researchers 
globally, and second, the launch of the soli- 
darity trial which has at least 10 countries in 
participation with the WHO at the helm of the 
study. Those two observations are marks of 
international coordination and cooperation. 
During this COVID-19, we have seen coun- 
tries help each other; from donating venti- 
lators to taking in very critical patients (26). 
Furthermore, the United Nations (UN) beli- 
eves that ”the only way to fight COVID-19 is 
through a global approach” and in demon- 
stration of its commitment to humanitarian 
response has donated USD 2 billion to assist 
51 countries across the globe to cushion the 
effect of COVID-19 (27). More international 
collaborations will be needed to facilitate 
vaccine delivery and break the barriers to 
vaccine licensing. LMICs will require great 
help to bounce back from the heavy blow of 
COVID-19, and this can only come through 
international solidarity. 
 According to the World Health Organ- 
ization 2016 [13], ”a well-functioning health 
system working in harmony is built on having 
trained and motivated health workers, a well 
maintained infrastructure and a reliable sup- 
ply of medicines and  technologies backed by 
adequate funding, strong health plans and 
evidence -based policies.” The weak health 
system in Africa was heavily exposed during 
the Ebola outbreak that began in Guinea in 
2013, and spreading to Liberia and Sierra 
Leone in 2014 (14,15). The Republic of 
Guinea suffers from a critical shortage of 
healthcare workers with a health workforce 
density less than 1.5 per 10,000 (14). 
Apanga and Akparigbo (15) reported that 
80% of Ebola cases in the early days of the 
outbreak who were diagnosed of Ebola were 
not admitted by the hospital authorities due 
to lack of infrastructure (accommodation). 
Poor infrastructure and weak health systems 
continue to plague many LMICs in the face of 
the recent COVID-19. To improve the COVID-
19 response, national governments must pay 
more attention to their health systems by 
increasing funding, quality and quantity of 
their health workforce (16). This view is 
reemphasized by Bill Gates (17) who believes 
that “it’s essential to help LMICs strengthen 
their primary health care systems. When you 
build a health clinic, you are also creating 





 By joining together and engaging 
communities, COVID-19 can be contained 
just like the EVD. It is important to note that 
the world will only be safe when we are all 
safe. The COVID-19 pandemic has exploited 
any and all cracks in humanity. In the war 
against COVID-19, health system resilience, 
accountability and integrity are more impor- 
tant than ever. The health systems of some 
high-income-countries have become overwh- 
elmed by the rising number of infected cases 
and deaths from the disease. The weaker, 
corruption-prone and less resilient health 
systems of many LMICs are even more 
vulnerable, and some may even collapse. 
 The 2014-2016 outbreak in West 
Africa has been described severally as the 
largest and most complex of all Ebola out- 
breaks (18), the first case was reported on 
March 23, 2014 in South Eastern Guinea (19). 
An important lesson learnt is that outbreak 
response requires concerted effort and should 
not be left for any one government or organi- 
zation (20). The importance of international 
collaboration was demonstrated when the 
international community committed USD 100 
million to fight the Ebola epidemic of 2014-
2016 which enabled the deployment of more 
medical personnel to assist in combating 
Ebola (21). The cross-border collaboration on 
preparedness and response to Ebola virus 
and other disease outbreaks which DRC 
entered in 2019 with 9 neighboring countries 
is a sign of strong international commitment 
and willingness to pull resources which will 
strengthen disease surveillance among the 
participating countries and improve health 
  Research has underscored the vulne- 
rability of Africa’s health system. A consis- 
tently solid and accountable health system 
has eluded the continent. The requisite health 
resources are also in short supply. Also, 
Ebola and COVID-19 have demonstrated the 
need for universal health coverage. According 
to Tedros Adhanom (WHO Director General), 
“global health is only as strong as its weakest 
link”. Whether it is Ebola, COVID-19, measles, 
chickenpox or another pathogen, universal 
health coverage is our best defense. This 
means investing in surveillance, health work- 
force and primary health care as key compo- 
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